{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:25:21Z","timestamp":1761197121503,"version":"3.37.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.cyto.2012.09.016","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T20:15:13Z","timestamp":1351973713000},"page":"194-198","source":"Crossref","is-referenced-by-count":13,"title":["Elevated serum MMP-9\/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia"],"prefix":"10.1016","volume":"61","author":[{"given":"Marit S.","family":"Nenseter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingunn","family":"Narverud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asgeir","family":"Gr\u00e6sdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin P.","family":"Bogsrud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiv","family":"Ose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten B.","family":"Holven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2012.09.016_b0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2013 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.09.016_b0010","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2012.09.016_b0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.09.016_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tcm.2007.09.001","article-title":"Metalloproteinases and vulnerable atherosclerotic plaques","volume":"17","author":"Newby","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.cyto.2012.09.016_b0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","article-title":"Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction","volume":"54","author":"Packard","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.cyto.2012.09.016_b0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pcad.2008.09.001","article-title":"Atherosclerotic plaque stability\u2013what determines the fate of a plaque?","volume":"51","author":"Halvorsen","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cyto.2012.09.016_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.cyto.2012.09.016_b0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cyto.2012.09.016_b0045","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.85.24.9758","article-title":"Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins","volume":"85","author":"Weisgraber","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.09.016_b0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11936-006-0049-z","article-title":"LDL-apheresis therapy","volume":"8","author":"Moriarty","year":"2006","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.cyto.2012.09.016_b0055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOL.0b013e3283402f53","article-title":"Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe","volume":"21","author":"Thompson","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cyto.2012.09.016_b0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0021-9150(01)00633-5","article-title":"C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis","volume":"158","author":"Moriarty","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2012.09.016_b0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1526-0968.2003.00080.x","article-title":"Changes in C-reactive protein plasma levels during low-density lipoprotein apheresis","volume":"7","author":"Kojima","year":"2003","journal-title":"Ther Apheresis Dial"},{"key":"10.1016\/j.cyto.2012.09.016_b0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jca.10010","article-title":"The effects of three different LDL-apheresis methods on the plasma concentrations of E-selectin, VCAM-1, and ICAM-1","volume":"17","author":"Empen","year":"2002","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.cyto.2012.09.016_b0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0021-9150(98)00152-X","article-title":"LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia","volume":"141","author":"Rovers","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2012.09.016_b0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2004.03.011","article-title":"Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins\u2013reduction of circulating proinflammatory and procoagulatory markers","volume":"175","author":"Wang","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2012.09.016_b0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jca.20223","article-title":"Different inflammatory responses induced by three LDL-lowering apheresis columns","volume":"24","author":"Hovland","year":"2009","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.cyto.2012.09.016_b0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cyto.2011.04.003","article-title":"Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis","volume":"55","author":"Stefanutti","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2012.09.016_b0095","doi-asserted-by":"crossref","unstructured":"Gr\u00e6sdal A, Bogsrud MP, Holven KB, Nenseter MS, Narverud I, Langslet G, et al. Apheresis in homozygous familial hypercholesterolemia: results of 35 years of follow up of all Norwegian patients with homozygous familial hypercholesterolemia. J Clin Lipidol, in press. http:\/\/dx.doi.org\/10.1016\/j.jacl.2012.03.004.","DOI":"10.1016\/j.jacl.2012.03.004"},{"key":"10.1016\/j.cyto.2012.09.016_b0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cyto.2012.09.016_b0105","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"AtheroGene Investigators. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2012.09.016_b0110","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2362.2003.01189.x","article-title":"Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects","volume":"33","author":"Holven","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cyto.2012.09.016_b0115","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.STR.0000226465.84561.cb","article-title":"Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects","volume":"37","author":"Holven","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.cyto.2012.09.016_b0120","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/ndt\/gfn127","article-title":"Protein adsorption during LDL-apheresis: proteomic analysis","volume":"23","author":"Dihazi","year":"2008","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.cyto.2012.09.016_b0125","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cyto.2011.08.027","article-title":"Lipid and low-density-lipoprotein apheresis. effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia","volume":"56","author":"Stefanutti","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2012.09.016_b0130","first-page":"430","article-title":"Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans","volume":"49","author":"Nakamura","year":"2003","journal-title":"ASAIO J"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612007089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612007089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T15:23:17Z","timestamp":1540135397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466612007089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1043466612007089"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2012.09.016","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}